Tower Research Capital LLC (Trc) Myovant Sciences Ltd. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$24.03 - $27.02 $3.45 Million - $3.88 Million	143,775 Added 114.52%	269,319 $7.26 Million
Q3 2022 Nov 10, 2022	BUY	$11.6 - $20.44 $1.38 Million - $2.43 Million	119,074 Added 1840.4%	125,544 $2.26 Million
Q2 2022 Aug 15, 2022	SELL	$7.78 - $14.69 $110,880 - $209,361	-14,252 Reduced 68.78%	6,470 $81,000
Q1 2022 May 12, 2022	BUY	$11.38 - $16.4 $105,401 - $151,896	9,262 Added 80.82%	20,722 $276,000
Q4 2021 Feb 14, 2022	BUY	$14.31 - $23.87 $18,746 - $31,269	1,310 Added 12.91%	11,460 $179,000
Q3 2021 Nov 15, 2021	BUY	$18.94 - $26.99 $192,241 - $273,948	10,150 New	10,150 $228,000
Q2 2021 Aug 16, 2021	SELL	$17.07 - $24.56 $60,888 - $87,605	-3,567 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$20.46 - $25.18 $70,525 - $86,795	-3,447 Reduced 49.14%	3,567 $73,000
Q4 2020 Feb 16, 2021	BUY	$13.8 - $27.62 $96,793 - $193,726	7,014 New	7,014 $193,000
Q3 2020 Nov 16, 2020	SELL	$14.05 - $22.6 $258,337 - $415,546	-18,387 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$7.34 - $20.84 $87,059 - $247,183	11,861 Added 181.75%	18,387 $379,000
Q1 2020 May 15, 2020	BUY	$6.55 - $14.76 $9,517 - $21,446	1,453 Added 28.64%	6,526 $49,000
Q4 2019 Feb 07, 2020	SELL	$4.2 - $19.21 $19,605 - $89,672	-4,668 Reduced 47.92%	5,073 $79,000
Q3 2019 Nov 05, 2019	BUY	$5.19 - $9.46 $16,000 - $29,165	3,083 Added 46.31%	9,741 $51,000
Q2 2019 Aug 13, 2019	BUY	$8.69 - $25.0 $57,858 - $166,450	6,658 New	6,658 $60,000
Q3 2018 Nov 13, 2018	SELL	$19.33 - $26.78 $3,865 - $5,356	-200 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$19.2 - $25.14 $3,840 - $5,028	200 New	200 $5,000
Q1 2018 May 15, 2018	SELL	$12.46 - $21.32 $59,072 - $101,078	-4,741 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$11.37 - $16.4 $117,554 - $169,559	-10,339 Reduced 68.56%	4,741 $60,000
Q3 2017 Nov 14, 2017	BUY	$9.93 - $15.47 $149,744 - $233,287	15,080	15,080 $233,000

Others Institutions Holding MYOV

# of Institutions

Shares Held

61.3K

Call Options Held

Put Options Held

View Full List

About Myovant Sciences Ltd.

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

More about MYOV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account